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Abstract 
The generation of mutants and transgenes are indispensible for biomedical research. In the nematode Caenorhabditis 
elegans, a series of methods have been developed to introduce genome modifications, including random mutagen-
esis by chemical reagents, ionizing radiation and transposon insertion. In addition, foreign DNA can be integrated into 
the genome through microparticle bombardment approach or by irradiation of animals carrying microinjected extra-
chromosomal arrays. Recent research has revolutionized the genome engineering technologies by using customized 
DNA nucleases to manipulate particular genes and genomic sequences. Many streamlined editing strategies are 
developed to simplify the experimental procedure and minimize the cost. In this review, we will summarize the recent 
progress of the site-specific genome editing methods in C. elegans, including the Cre/LoxP, FLP/FRT, MosTIC system, 
zinc-finger nucleases (ZFNs), transcriptional activator-like nucleases (TALENs), and the clustered regularly interspaced 
short palindromic repeats (CRISPR)/Cas9 nuclease. Particularly, the recent studies of CRISPR/Cas9-mediated genome 
editing method in C. elegans will be emphatically discussed.
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Background
The nematode Caenorhabditis elegans is a model organ-
ism, which is widely used in genetic and biomedical 
research [1]. The C. elegans genome consists of approxi-
mately 97 mega base pairs and encodes roughly twenty 
thousand protein-coding genes (WormBase referential 
freeze WS254, May 2016), yet more than 40% of its genes 
have considerable homologies in other organisms [2]. 
In addition, a lot of genetically characterized nematode 
strains, including mutations and transgene integrations, 
can be easily obtained from the Caenorhabditis Genet-
ics Center (CGC), which considerably aid world-wide 
researchers [3].
Many genome engineering methods have been devel-
oped to induce random mutations and chromosomal 
structure alterations. Chemical mutagens, including 
ethyl methane sulfonate (EMS), N-ethyl-N-nitrosourea 
(ENU) and ultraviolet-activated trimethylpsoralen (UV/
TMP) [4, 5], are widely used to induce DNA lesions 
in forward genetic screens. Ionizing and UV radiation 
mutagenesis are typically employed to generate large 
sequence deletions or chromosomal rearrangements, 
such as chromosomal duplications, inversions and trans-
locations. Transposon-mediated insertional mutagenesis 
approaches, including Tc1 and Mos1 system, have been 
applied in genetic screens and significantly eased the 
identification of the putative mutations through an opti-
mized inverse PCR approach [4, 6]. Recently, an optoge-
netic mutagenesis method was developed by adopting the 
mini Singlet Oxygen Generator (miniSOG) system, which 
expands the toolbox for forward genetic screening [7].
Exogenous DNA fragments can be inserted into the 
C. elegans genome. After microinjection of a DNA plas-
mids mix solution into the gonad, the plasmids DNA 
undergoes intermolecular ligation and rearrangement to 
form multi-copy extrachromosomal DNA arrays which 
are semistable and inherited to a part of the progenies 
[8]. Thereafter, the extrachromosomal arrays can be sta-
bly integrated into the genome by mutagens or radia-
tions to generate high copy numbers of transgenes [9]. 
In addition, microparticle bombardment method was 
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successfully applied to directly produce low-copy inte-
grated transgenic lines in C. elegans [10]. High copy 
integrated arrays are prone to be silenced, yet low-copy 
transgenes permit relatively stable expression of proteins 
of interest in the C. elegans germline. Recently, Frøkjær-
Jensen et al. developed a miniMos strategy to arbitrarily 
insert single copy exogenous DNA fragments into the 
genome [11]. The miniMos is a truncated Mos1 transpo-
son that is loaded with large DNA fragments and insert 
into the chromosome at high frequency through co-
injection of plasmid expressing the Mos1 transposase. A 
limited number of C. elegans strains carrying the mini-
Mos1 site have been created to facilitate this single-copy 
transgene integration.
Although the genome-wide mutagenesis methods are 
broadly used to create nematode strains with mutations 
or integrated transgenes, sequence-specific gene edit-
ing are hardly achieved through these approaches. Great 
efforts have been devoted to develop a series of targeted 
genome editing technologies in C. elegans, including 
Cre/LoxP and FLP/FRT recombination, Mos1 excision-
induced transgene-instructed gene conversion (MosTIC), 
zinc-finger nucleases (ZFNs), transcription activator-like 
effector nucleases (TALENs) and the recent developed 
clustered regularly interspaced short palindromic repeats 
(CRISPR) RNA-guided Cas9 nuclease technology. These 
methods, especially the CRISPR/Cas9 technology, 
remarkably assist the generation of nematode strains 
with desired sequence alterations on genes of interest.
In this review, we will summarize these site-specific 
genome engineering technologies and discuss the optimi-
zation of these methods to provide appropriate genome 
editing strategies for different purposes.
FLP/FRT and Cre/LoxP recombination technologies
FLP/FRT and Cre/LoxP systems are broadly applied to 
modify genome to induce chromosomal rearrangements 
[12, 13] and conditionally activate or inactivate gene 
expression [14]. The site-specific recombinases Flp and 
Cre recognize the FRT (for short flippase recognition tar-
get) and LoxP (for locus of X-over P1) sites, respectively. 
Then Flp and Cre catalyze the recombination of two FRT 
sites and LoxP sites, to induce excision or inversion of the 
flanked DNA segment, depending on the orientations of 
the two repeat elements. These recombination-mediated 
editing methods have been successfully applied to induce 
sequence deletions or inversions in vivo to control gene 
expression in C. elegans [14]. Typically, repeats with the 
same orientation result in an excision of the contained 
DNA segment, while inverted repeats lead to inversion 
of the DNA sequences between the two repeat elements. 
Thus, a particular gene can be activated by inverting an 
originally inverted promoter or coding sequence, or by 
eliminating a DNA fragment containing a transcriptional 
stop. Similarly, genes can be inactivated through the 
removal of the promoter or coding regions. Conditional 
gene manipulation is achieved via the spatial or temporal 
expression of recombinases, driven by tissue specific pro-
moters or a heat shock promoter. In addition, the FLP/
FRT and Cre/LoxP approaches are used in conjugation 
with the single-copy transgenic technologies to facilitate 
the removal of co-integrated positive selection markers, 
which are flanked by LoxP or FRT sites, and streamline 
the construction of transgenic animals [15–19].
MosTIC‑induced targeted gene conversion
Mos1 transposon, a member of the mariner/Tc1 family, 
was originally identified in the fruit fly Drosophila mau-
ritiana. Mos1 transposon can randomly insert into the C. 
elegans genome by Mos1 transposase-mediated cleavage 
and integration processes [20, 21]. Thereafter, for animals 
with integrated Mos1 transposons at particular genome 
locations, the transient expression of Mos1 transposase 
through extrachromosomal array under the heat-shock 
promoter Phsp-16.48 or germline specific promoter Pglh-
2 can induce chromosomal breaks at the Mos1 site on 
the genome [22, 23]. These double-strand breaks (DSB) 
are further repaired, in the presence of donor repair tem-
plates, to elicit precise sequence alterations, including 
point mutations, deletions and insertions [23, 24]. The 
Mos1 excision-induced transgene-instructed gene con-
version (MosTIC) system, like the Cre/LoxP and FLP/
FRT method, relies on the prior presence of animals 
containing Mos1 insertion sites at the destined genomic 
locus. A library of nematode strains with Mos1 insertion 
sites have been generated by the NemaGENETAG con-
sortium for the C. elegans community [25, 26].
A Mos1-mediated single-copy insertion (MosSCI) 
system has been developed to construct single copy 
transgenic lines [27]. A number of C. elegans strains 
were engineered with Mos1 elements inserted at cer-
tain intergenic genomic loci for the routine insertion of 
transgenes. The single copy transgenes likely express the 
recombinant proteins at normal physiological levels and 
escape the small RNA-mediated transgene silencing in 
the germline. Therefore, the MosSCI method provides 
a platform to investigate the genes involved in germline 
development and progeny propagation.
ZFNs and TALENs create DNA lesions through the utility 
of sequence‑specific DNA‑binding modules
Site-specific nucleases mediated targeted genome engi-
neering has been demonstrated to be a wide applicable 
solution for effective genome manipulation in a vari-
ety of organisms. These engineered nucleases cleave 
specific genomic locus via the use of custom-designed 
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DNA binding domains that recognize destined DNA 
sequences. Two of methods, ZFNs and TALENs, have 
been well developed and applied to genome editing in 
many organisms, including C. elegans.
ZFNs are artificially engineered proteins generated by 
fusing tandem Cys2His2 zinc finger domains with a DNA 
cleavage domain from the restriction endonuclease FokI 
[28]. One zinc finger module recognizes a particular 3-bp 
DNA sequence, thus three zinc finger modules are typi-
cally linked together to confer a zinc finger protein (ZFP) 
that binds 9-bp DNA sequences (Fig.  1a). FokI nuclease 
cleaves DNA adjacent to the binding site to elicit a DSB. 
Since the catalytic domain of FokI must dimerize to be 
active, two ZFN nucleases are usually engaged at the same 
time, which allows a combined recognition sequence of 
18-bp. More recent studies use ZFNs with 4, 5 or 6 zinc 
fingers to specify longer and rarer cleavage targets, yield-
ing less off-target activity. The DSBs were then repaired 
through non-homologous repair processes that further 
introduce mutations at the cleavage site. Theoretically, 
ZFNs can be designed to cleave DNA at any genomic loci 
by combining distinct zinc finger modules with different 
specificities. Morton et al. reported that ZFNs can induce 
targeted DSBs on extrachromosomal and chromosomal 
targets in nematode somatic cells at high frequency [29]. 
Wood et al. utilized this method to modify genes in the 
germline to generate heritable mutations of selected 
genes, including integrated exogenous gfp sequence and 
endogenous genes, ben-1 and rex-1 [30].
TALENs function like ZFNs, except that the non-
specific FokI nuclease is fused to tandem transcription 
activator-like (TAL) domains. TAL effectors (TALEs) 
are proteins produced by Xanthomonas bacteria when 
they infect plants [31]. In host plant cells, TALEs bind 
specific promoter sequences and regulate gene expres-
sion to assist infection. Typically, TALEs bind target 
DNA sequence via tandem repeats of 34 amino acids 
monomers. Each repeat is highly conserved and dif-
fers only by two variable amino acids at positions 12 
and 13, which are called the repeat variable di-residues 
(RVDs) that determine the DNA-binding specificity [32, 
33]. Unlike zinc fingers domain, each TAL domain just 
binds to a single nucleotide, rather than three nucleotides 
(Fig. 1b). The serially combined TAL domains direct the 
FokI nucleases to desired genomic DNA sequences and 
generate DNA lesions. TALENs has been successfully 
applied to induce heritable genome editing of a series of 
C. elegans genes [16, 30]. Precise knockins via homology 
directed repair (HDR) has also be accomplished through 
the TALENs technology by exogenously supplying single 
strand DNA oligonucleotides (ssODNs) as a repair tem-
plate for HDR [16]. Recently, Cheng et  al. developed a 
strategy to generate inducible gene knockouts via tempo-
ral or spatial expression of somatic TALENs [34].
    N N A T C G A C G C T N N N N N N G A A C T G T A C N N 







    N N A T C G A C G C T N N N N N N G T C C T G T A C N N 









Fig. 1 Schematic representation of the ZFN and TALEN pairs. a Illustration of a pair of ZFNs bound to specific DNA sequences. Zinc finger modules 
are shown as rounded rectangle boxes. Each zinc finger binds to a particular nucleotide triplet. b Illustration of a pair of TALENs. TALE modules are 
represented as ellipses and each recognizes a specific nucleotide. The DNA binding domains of ZFN and TALEN are fused to a cleavage domain of 
FokI nuclease, therefore guide the FokI nuclease to the desired genomic loci and cleave the flanked spacer sequences
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The CRISPR/Cas9 system is directed by small guide RNA 
to cleave targeted DNA sequences
Although ZFNs and TALENs provide a platform for 
targeted genome editing efficiently with less sequence 
requirements than the MosTIC system, the processes 
to design and build the sequence specific nucleases are 
time-consuming, cumbersome and expensive, which hin-
der their applications. Recently, the clustered regularly 
interspaced short palindromic repeats (CRISPR) RNA-
guided Cas9 nucleases has revolutionized the genome 
engineering technologies in numerous organisms [35]. 
The CRISPR/Cas9 technology is a versatile RNA-directed 
genome editing method that uses small guide RNA to 
recognize complementary DNA sequences, direct Cas9 
nucleases to the targeted site, and elicit DSBs.
The CRISPR/Cas system is a heritable and adaptive 
immune system presenting in bacteria and archaea, 
which confers resistance to foreign genetic elements 
that are embedded within plasmids or phages [36]. Clus-
tered regularly interspaced short palindromic repeats 
(CRISPR) are segments of repeated sequences sepa-
rated by unique short spacer DNA elements originated 
from the DNA of a previously exposed bacteriophage 
or plasmids. Generally, a long precursor CRISPR RNA 
(pre-crRNA) is transcribed from the CRISPR region and 
subsequently processed by Cas nucleases and accessory 
factors to form a mature crRNA. Through the combined 
action of crRNA and Cas proteins, the targeted DNA 
sequence can be recognized and cleaved to defense the 
infection of invaded nucleic acids.
Among diverse Cas proteins, the Cas9 nuclease from 
the type II CRISPR system, has been most widely used for 
genome editing in a series of organisms. Cas9 is directed 
to DNA sequences by a duplex of two RNAs: the crRNA 
that contains a 20-nt guide sequence recognizes the tar-
geted DNA and the supporting trans-activating crRNA 
(tracrRNA) that hybridizes with the crRNA and binds to 
the Cas9 protein [37]. Current CRISPR system fuses the 
crRNA–tracrRNA duplex into a chimeric single guide 
RNA (sgRNA) [35] (Fig.  2). The 20-nt guide sequence 
located at the 5′-end of the sgRNA complements to the 
targeted DNA sequence via Watson–Crick base-pairing. 
A protospacer adjacent motif (PAM) immediately down-
stream the targeted site in the DNA sequence is required 
for the cleavage reaction by Cas9 nuclease, which further 
increases the specificity of target recognition. The Cas9 
nuclease can be guided to cleave any desired genomic 
sequence that contains a GG dinucleotide, which provide 
a high versatility to choose the targeted editing locus. 
DSBs are then generated by Cas9 nuclease. As a conse-
quence of non-homologous end joining (NHEJ) repair, 
mutations will be introduced at the desired site.
The CRISPR/Cas9 technology has been successfully 
applied to induce heritable gene alterations in C. ele-
gans [15, 16, 38–44]. A number of methods to deliver 
the Cas9 protein and sgRNA to the germline have been 
developed. Plasmids that express Cas9 protein under the 
eft-3 promoter or hsp-16.48 heat-shock promoter and 
sgRNA under a U6 promoter are constructed to drive 
the expression of Cas9 and sgRNA in the germline after 
a microinjection into the gonad [39, 41, 44]. Addition-
ally, in vitro transcribed sgRNA and Cas9 mRNA or puri-
fied Cas9 protein can also be introduced into the gonad 
by microinjection [16, 40, 42, 43]. Interestingly, Liu et al. 
developed a CRISPR-Cas9 feeding system that feeds the 
Ppie-1::Cas9 transgenic animals with bacteria expressing 
sgRNA, which may facilitate high throughput genetics 
screening [45].
In addition, conditional gene knockout can be achieved 
by using a somatic expressed Cas9 protein under a tis-
sue specific promoter or a heat-shock promoter [45–47]. 
Therefore, DNA indels are generated at predetermined 
developmental stages in specified somatic tissues of C. 
elegans, which produce tissue specific loss-of-function 
phenotypes.
Besides imprecise genome editing via non-homol-
ogous end joining and DNA repair, the CRISPR/Cas9 
system can precisely modify a target sequence through 
HDR under the guidance of exogenously supplied DNA 
templates [15, 39, 40, 44, 48–51]. A number of repair 
templates have been used in C. elegans, including short 
ssODNs and long double-strand DNA, such as plasmids 
and PCR-generated DNA fragments. The plasmid DNA 
templates usually carry 300–2000  bp of homologous 
sequence arms flanking the desired modifications [15, 40, 
44]. Point mutations and large DNA fragments insertions 
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Fig. 2 Schematic of the CRISPR/Cas9 system. Cas9 nuclease 
is directed by small guide (sg)RNA to cleave the desired DNA 
sequences. The first 20-nt of the sgRNA recognize its targeted DNA 
through base-paring interaction. A PAM motif on the DNA target is 
required for the enzymatic activity of Cas9 protein. The RuvC and 
HNH endonuclease domains of Cas9 cleaves one strand of DNA, 
respectively, to generate a double-stranded DNA break approxi-
mately 3 bp upstream of the PAM
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can be introduced into the genome through the use of 
plasmids. Interestingly, Paix et  al. reported a conveni-
ent method by using a linear PCR fragment with short 
homology arms, which bypasses the plasmid construc-
tion process [49, 52]. The optimal length of the homology 
arms was estimated to be roughly 30- to 60-bp. Other 
groups also used a short ssODNs to direct precise edit-
ing [48–51, 53, 54]. ssODNs can be chemical synthesized 
and directly microinjected into the gonad without ampli-
fication or cloning procedures. Usually, a donor ssODN 
contains the desired nucleotide variation(s) flanked by 
30-80 nucleotides on both sides that match the targeted 
sequence.
In addition to editing a single gene, the CRISPR/Cas9 
technology has been applied to manipulate chromosomes 
and elicit chromosomal rearrangements [55–57]. A num-
ber of DSBs can be introduced in the presence of multiple 
sgRNAs simultaneously. Thereafter, large genomic frag-
ments can be reversed, deleted, or translocated to other 
chromosomal loci. For example, our lab has reported the 
use of dual sgRNA strategy to direct reciprocal chromo-
somal translocations in C. elegans [58]. The nematode 
strains with specific chromosomal rearrangements can 
serve as genetic balancers for the screening and mainte-
nance of essential genes [59].
Recent progress has developed the CRISPR interfer-
ence (CRISPRi) and CRISPR-on strategies to regulate 
gene transcription in C. elegans [60]. A catalytically inac-
tive form of Cas9, dCas9, was fused with transcription 
activator or repressor to modulate gene expression at or 
near their endogenous expression location(s) through 
target-specific gRNAs (ts-gRNAs). In addition, a DNA 
methyltransferase can be fused to dCas9 to sequence 
specially methylate genome DNA in mammalian cell 
lines [61].
Optimization of sgRNA and Cas9 protein
Although a series of editing experiments have been 
performed with the use of many different sgRNAs and 
various delivery strategies, there is still a lack of system-
atic prediction of the cleavage efficiency of a particular 
sgRNA. It is pivotal to develop strategies to design sgR-
NAs with higher efficiency. The combination of multiple 
sgRNAs targeting the same gene was shown to improve 
cleavage efficiency [49, 58, 62]. Farboud and Meyer 
reported that guide RNAs with a GG motif at the 3′ end 
of their target sequences can dramatically improve the 
editing efficiency [63]. A modified sgRNA (F + E) with an 
extended Cas9 binding structure yet lack of a putative Pol 
III terminator increased activity in both mammalian cells 
and C. elegans [54, 64].
The requirement for a PAM motif in the targeted DNA 
limits the choice of sgRNA sequences. To overcome this 
constraint, modified Cas9 nucleases with altered PAM 
specificities have been developed that expand the target 
repertoire and ease the high-throughput fluorescent pro-
tein tagging of endogenous genes [65]. For example, Bell 
et  al. have successfully applied two modified Cas9 pro-
teins that recognize NGA and NGCG PAM respectively 
to C. elegans [66].
Efficient identification of genome‑modified C. elegans strains
Animals with targeted gene modifications can be 
obtained through phenotypic analysis and PCR screen-
ing. Animals with morphological changes, such as Dpy, 
Unc and Rol, can be easily visualized and selected. Inte-
grated transgenic lines tagged with fluorescent proteins 
can be identified under a fluorescence microscope. For 
genes of which loss-of-function result in no obvious phe-
notypes, the mutations can be detected via PCR screen-
ing. The PCR amplicons surrounding the sgRNA sites can 
be analyzed using T7 endonuclease I (T7E1) or restric-
tive endonuclease digestion. Moreover, simultaneous 
introduction of multiple sgRNAs lead to the removal of 
large DNA chunks between the sgRNAs, which simplifies 
the identification of deletion mutants by PCR amplifica-
tion followed by agarose gel electrophoresis [58, 62]. The 
integrated transgenes can be identified by PCR amplified 
with appropriate primers as well.
Several screen methods have been developed to assist 
the identification of genome editing events in C. elegans. 
Kim et  al. used a co-CRISPR strategy with two sgR-
NAs to simultaneously edit the genome [50], of which 
one acts as a co-sgRNA to induce an easily recogniz-
able phenotype and the other sgRNA targets the gene 
of interest (Fig. 3a). The visible phenotype generated by 
the co-sgRNA allows to identify animals in which Cas9 
is active to edit genomic DNA. The co-CRISPR strategy 
dramatically increased the frequency of detecting NHEJ 
or HDR events targeting specified genes. Arribere et  al. 
further optimized this co-CRISPR method and devised a 
co-conversion strategy to detect gene editing events via 
the application of several gain-of-function alleles [51], 
in which a donor template was co-injected simultane-
ously to create a dominant marker mutation (Fig.  3b). 
The co-conversion strategy provides a platform for effi-
cient marker-free recovery of HR directed precise genetic 
modifications. Ward then used a temperature-sensitive 
lethal mutation of the pha-1 gene as a co-conversion 
marker and deactivated the NHEJ repair pathway via 
cku-80 RNAi during the co-conversion procedure [54]. 
Animals rescued the pha-1(e2123) mutation were then 
selected and genotyped.
Selectable markers, including phenotypic selection 
markers and antibiotic-resistance markers, are inserted 
into the genome together with the desired genome 
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alterations, to assist the detection of HDR events and 
the identification of integrated transgenic animals. 
Cbr-unc-119(+), a marker commonly employed in the 
MosSCI-mediated genome editing technology, has been 
applied to isolate CRISPR/Cas9-induced insertions by 
rescuing of a visible Unc phenotype [15]. Antibiotic-
resistance markers, such as resistance against blastici-
din, hygromycin and neomycin, are also used for mutants 
selection [18, 44, 50]. Additionally, the benomyl resist-
ance provides an alternative counter selection strategy 
for targeted knock-in of specific DNA fragments at the 
ben-1 locus [44]. While wild-type animals exhibit a vis-
ible paralysis phenotype when exposed to benomyl at 
25 °C, the loss of function of ben-1 by targeted transgene 
insertion confers benomyl resistance [58].
Several selection cassettes, each containing a visible 
phenotypic marker and an antibiotic-resistance marker, 
have been created to construct versatile plasmid vec-
tors in conjunction with other functional DNA elements, 
which act as templates for homologous repair in C. ele-
gans. For example, Norris et  al. devised a dual-marker 
selection system that using a repair cassettes containing 
an antibiotic resistance gene (Prps-27::neoR) and a fluo-
rescent visual marker (Pmyo-2::gfp) [17]. The antibiotic 
marker is used to detect worms carrying the repair tem-
plates and the fluorescent marker enables convenient 
selection of homologous recombinants. The cassette, 
flanked by LoxP sites, is inserted into an intron of gfp 
sequence and can be easily removed from the recombi-
nant genome by injecting the plasmid expressing Cre 
recombinase in the germline. Dickinson et al. developed 
a self-excising cassette (SEC) for rapid identification of 
fluorescent protein knock-ins events [18]. The SEC is 
composed of three components: a drug-resistance gene 
(hygR), a visible phenotypic marker [sqt-1(e1350)], and 
a heat-inducible Cre recombinase. The SEC is flanked 
by LoxP sequences and can be easily excised from the 
genome after a heat shock treatment. These methods 
Peft-3::cas9 rol-6 marker
sgRNA gene x sgRNA unc-22
microinjection
screen for F1 twitchers and F1 
rollers with twitching F2 progeny  
pick wildtype F2, screen for 









screen F1 for Rol
screen for gene x(mut) via 
F1 single worm genotyping
pick non-Rol F2, screen for 
homozygous gene x(mut)  
screen for homozygous 
gene x(mut) 
a b
screen for gene x(mut) via 
F1 single worm genotyping
Fig. 3 The co-CRISPR and co-conversion strategies for the detection of targeted genome modifications. a The co-CRISPR strategy used rol-6(su1006) 
expression plasmid as a co-injection marker and an unc-22 sgRNA as a co-editing marker. F1 animals with both twitching and rolling phenotypes 
are selected. The twitching F2 animals are further screened by single worm PCR to identify the animals with gene X mutation. b The co-conversion 
strategy used a donor oligonucleotides carrying the rol-6(su1006) mutation as both co-injection and editing marker. F1 roller animals are screened 
by single worm PCR to identify the animals with gene X mutation. The figure was adapted from Arribere et al. [51]
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greatly minimized the time and labor requirements to 
identify precise genome modifications, enabled robust 
selection without large-scale PCR screening, and pro-
vided a streamlined platform for genome-wide fluores-
cent protein knock-ins.
High‑throughput genome editing by CRISPR/Cas9 technology
The direct application of in vitro synthesized sgRNA and 
purified Cas9 protein have greatly eased the genome edit-
ing experiments, yet recent efforts are devoted to sim-
plify the construction of vectors expressing sgRNA and 
plasmids containing homologous repair templates. These 
methods streamlined the procedure for high-throughput 
genome editing by the CRISPR/Cas9 technology.
Ward utilized fusion PCR approach to generate lin-
ear DNA fragments to express sgRNA, bypassing the 
molecular clone steps [54]. Schwartz and Jorgensen 
have designed a convenient modular plasmid assembly 
strategy with high efficiency, termed as SapTrap [19]. In 
this method, all target specific DNA fragments, includ-
ing guide RNA and short homology arms, are provided 
as annealed synthetic oligonucleotides. Other invariant 
modular components, including tag and marker cassettes 
and connector modules (CNCTR) are derived from the 
donor plasmids, which are digested by the restriction 
enzyme SapI. These components are ligated in a fixed 
order to produce the targeting vector, using the Golden 
Gate assembly method. Moreover, the authors have gen-
erated a SapTrap donor plasmids library that supplies a 
variety of tags and connectors, allowing flexible tagging 
at specified genomic locus.
Paix et  al. developed an in  vivo recombination strat-
egy to induce gene conversions in C. elegans [67]. This 
method combined short ssODNs and PCR fragments to 
introduce desired DNA sequences into specific genomic 
loci. The overlapping ssODNs initiate DNA repair 
in vivo and, assemble with each other to form an entire 
fragment, and are effectively inserted into the genome. 
ssODNs bridge multiple PCR fragments to chromosomal 
breaks, and induce an efficient insertions of the PCR 
fragments to defined genomic loci. This method elimi-
nates the cumbersome and time-consuming molecular 
cloning procedures.
Conclusions and perspectives
Genome engineering methods have marvelously pro-
moted the forward and reverse genetic studies in C. 
elegans. Genome wide random mutagenesis can be con-
ducted with diverse strategies, including chemical rea-
gents, high-energy radiation and transposon insertions. 
Targeted genome editing technologies, which use site 
specific DNA nucleases to induce genome modifica-
tions, have tremendously simplified the manipulation of 
a selected DNA sequence in vivo. By combining both for-
ward and reverse genetics, the function and mechanism 
of genes and biological processes can therefore be thor-
oughly investigated.
Many mutants, especially mutants with missense point 
mutations, exhibit no obvious phenotypes in various spe-
cies including C. elegans. The reason could be the lack of 
observable phenotypes that the researchers investigated 
or gene compensations. In addition, many genes show 
synthetic phenotypes or only reveal noticeable defects 
under stress conditions. Therefore, null or multiple inde-
pendent alleles are usually required to pinpoint the func-
tion of genes.
Distinct site-specific genome engineering technologies 
can be used according to the particular editing aims. The 
recombinases used in the Cre/LoxP, FLP/FRT systems 
and the mos1 transposase utilized in the Mos1 systems 
exclusively recognize specified DNA sequences, and 
therefore require for particular C. elegans strains carry-
ing these sequence elements. On the other hand, ZFNs, 
TALENs and CRISPR can be engineered to recognize 
arbitrary DNA sequences in the genome and induce 
editing events independent of the prior existence of cer-
tain sequence elements. The pros and cons of different 
genome engineering tools and their applications in worm 
study are summarized in Table  1. Although the recent 
development of CRISPR/Cas9 technology has greatly 
simplified the gene manipulation processes with higher 
efficiency and wider applications, the non-CRISPR/Cas9 
techniques can be used in combination with the Cas9 
system to establish streamlined genome editing proce-
dure. For example, researchers have combined Cre/LoxP 
and FRT/FLP recombination systems with CRISPR/Cas9 
technology to conduct genome engineering experiments 
to acquire tagged animals.
Many genes play pleiotropic roles in various tissues 
or at different developmental stages. The conditional 
genome editing methods greatly facilitated the manipu-
lation of these genes, by controllable gene activation or 
inactivation. The loss-of-function mutation of essential 
genes can be easily generated and maintained through 
the combination of CRISPR/Cas9 technology and the 
balancer system. High throughout genome editing, espe-
cially genome-wide fluorescent protein tagging, should 
be of much significance for the C. elegans community. 
In C. elegans, several groups have previously undertaken 
genome-wide expression projects by using extrachromo-
somal promoter::GFP or promoter::CDS::GFP reporters. 
Yet tagging fluorescence proteins into endogenous genes 
using the CRISPR/Cas9 technique will represent the 
native expression patterns and regulations. The recent 
developed editing strategies based on the optimization 
of the repair templates construction and the simplified 
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screening methods for modified animals, provide the 
possibility to obtain a library of nematode strains with 
mutation or tagging of every single gene. Further opti-
mization of the experimental operations will smooth the 
creation of these libraries to accelerate the research of C. 
elegans biology.
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